Full Length Research Paper
References
|
Balm MND, La MV, Krishnan P, Jureen R, Lin RZP, Teo JWP (2013). Emergence of Klebsiella pneumonia co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect. 19:421-423. Crossref |
||||
|
Castanheira M, Deshpande LM, Farrell SE, Shetye S, Shah N, Jones RN (2013). Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn. Microbiol. Infect. Dis. 75:210–213. Crossref |
||||
|
Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE (2011). Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother. 55:1274–1278. Crossref |
||||
|
Cuenca FF, Martínez-Martínez, L, Conejo M, Ayala JA., Perea EJ, Pascua A (2003). Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565–574. Crossref |
||||
|
Diana D, Gisele P, Christine L, Tracie L, Deirdre LC, Johann DD Pitout (2012). Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases. J. Clin. Microbiol. 50(12): 3877–3880. Crossref |
||||
|
Duijn PJV, Dautzenberg MJ, Oostdijk EA (2011). Recent trends in antibiotic resistance in European ICUs. Curr. Opin. Crit. Care 17:658–665. Crossref |
||||
|
Duin DV, Keith SK, Elizabeth AN, Robert AB (2013). Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75:115–120. Crossref |
||||
|
Frank MK, Fadia DH, Wenchi S, Thomas DG (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 _-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrob. Agents Chemother. 50(10):3396–3406. Crossref |
||||
|
Jacoby GA, Mills DM, Chow N (2004). Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumonia. Antimicrob. Agents Chemother. 48:3203–3206. Crossref |
||||
|
Jamal W, Rotimi VO, Albert MJ, Khodakhast F, Udo EE, Poirel L (2012). Emergence of nosocomial New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int. J. Antimicrob. Agents 39:183-185. Crossref |
||||
|
James CE, Mahendran KR, Molitor A, Bolla JM, Bessonov AN, Winterhalter M, Pages JM (2009). How β - lactam Antibiotics enter bacteria: a dialogue with the porins. PLoS ONE 4(5):e5453. Crossref |
||||
| Kilic A, Aktas Z, Bedir O, Gumral R, Bulut Y, Stratton C, Tang YW, Celal BA (2011). Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey. Ann. Clin. Lab. Sci. 41:2. | ||||
|
Korzeniewska E, Harnisz M (2013). Beta-lactamase-producing Enterobacteriaceae in hospital effluents. J. Environ. Manage. 123:1-7. Crossref |
||||
|
Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH (2007). First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health care system. Antimicrob. Agents Chemother. 51:4015-4021. Crossref |
||||
| Mansouri S, Abbasi S (2010). Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran. Iran J. Med. Sci. 35:101-108. | ||||
|
Michael RM, Jennifer MG, Katherine P, Diane R, David AB (2011). New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg. Infect. Dis. 17(1): 103 –106. Crossref |
||||
|
Mohamed HA, Shibl AM, Elkhizzi NA, Meunier D, Turton JF, David ML. (2013). Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn. Microbiol. Infect. Dis. 76:214–216. Crossref |
||||
|
Pfeifer Y, Schlatterer K, Engelmann E, Schiller RA, Frangenberg HR, Stiewe D, Holfelder M, Witte W, Nordmann P, Poirel L (2012). Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German Hospitals. Antimicrob. Agents Chemother. 56:2125–2128. Crossref |
||||
|
Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F (2011). First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob. Agents Chemother. 55:4398 – 4401. Crossref |
||||
|
Pitout JDD, Laupland KB (2008). Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-66. Crossref |
||||
|
Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P (2011). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. Crossref |
||||
|
Prabaker K, Weinstein RA (2011). Trends in antimicrobial resistance in intensive care units in the United States. Curr. Opin. Crit. Care 17: 472–479. Crossref |
||||
|
Rhomberg PR, Jones RN (2009). Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn. Microbiol. Infect. Dis. 65:414–426. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
